Häkkinen, Margareeta
Tourunen, Jouni
Pitkänen, Tuuli
Simojoki, Kaarlo
Vuoti, Sauli
Article History
Accepted: 3 May 2022
First Online: 2 June 2022
Declarations
:
: The use of anonymized register data for research has been approved by the A-Clinic Foundation’s Ethical Committee for Treatment and Research and by the Finnish Institute for Health and Welfare. (Decision number: 11.10.2019; 1266/5.05.00/2019).
: Not applicable.
: Dr. Häkkinen reports receiving grants from MSD Finland Oy, Immuno Diagnostics, Indivior, and Abbvie. Prof. Simojoki reports receiving grants from Gilead, Abbvie, MSD Finland, Invidior, Nordic Drugs, Camurus and OnePharma. Dr. Vuoti is currently employed by Janssen Finland Oy, but conducted all work reported in this paper before the start of this employment relationship. Dr. Tourunen currently works and Dr. Pitkänen previously worked as independent researchers at the headquarters of the A-Clinic Foundation, a non-profit, non-governmental organization in the field of addictions whose subsidiary A-Clinic Ltd. provides treatment and rehabilitation services.